Study design, materials and methods
The present study was a single-blind randomized clinical trial.
In this clinical trial, 81 children with fecal incontinence were randomized into three groups:
Standard medical care (control)
Combined tecartherapy+ biofeedback
Biofeedback alone
The participants were randomly divided into three intervention groups . Control group: routine medical care including diet and lifestyle modification and laxative consumption Intervention group 1: biofeedback therapy , 2 sessions a week and Intervention group 2, biofeedback therapy along with tecar therapy ,2 sessions a week
This study will have a 6-week intervention time .
Primary and secondary outcomes measured over six weeks included:
The severity of incontinence based on the Rintala Pediatric Incontinence Questionnaire
The severity of constipation according to the Pediatric Constipation Severity Index [2].
The frequency of incontinence episodes per week
Interpretation of results
The enhanced efficacy of combined tecartherapy [3] suggests synergistic effects on pelvic floor muscle recruitment and rectal sensitivity modulation. The non-invasive nature of both modalities supports their safety profile in pediatric populations.